BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15659650)

  • 1. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.
    Ou YH; Chung PH; Sun TP; Shieh SY
    Mol Biol Cell; 2005 Apr; 16(4):1684-95. PubMed ID: 15659650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
    Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
    Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chk1-dependent constitutive phosphorylation of BLM helicase at serine 646 decreases after DNA damage.
    Kaur S; Modi P; Srivastava V; Mudgal R; Tikoo S; Arora P; Mohanty D; Sengupta S
    Mol Cancer Res; 2010 Sep; 8(9):1234-47. PubMed ID: 20719863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.
    Shieh SY; Ahn J; Tamai K; Taya Y; Prives C
    Genes Dev; 2000 Feb; 14(3):289-300. PubMed ID: 10673501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
    Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
    Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
    Urist M; Tanaka T; Poyurovsky MV; Prives C
    Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response.
    Ahn J; Urist M; Prives C
    J Biol Chem; 2003 Jun; 278(23):20480-9. PubMed ID: 12654916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.
    Craig A; Scott M; Burch L; Smith G; Ball K; Hupp T
    EMBO Rep; 2003 Aug; 4(8):787-92. PubMed ID: 12897801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 down-regulates CHK1 through p21 and the retinoblastoma protein.
    Gottifredi V; Karni-Schmidt O; Shieh SS; Prives C
    Mol Cell Biol; 2001 Feb; 21(4):1066-76. PubMed ID: 11158294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
    Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
    Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
    Huang H; Regan KM; Lou Z; Chen J; Tindall DJ
    Science; 2006 Oct; 314(5797):294-7. PubMed ID: 17038621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
    Carrassa L; Broggini M; Erba E; Damia G
    Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.